Loading provider…
Loading provider…
Medical Oncology Physician in Tampa, FL
NPI: 1003904889Primary Employer
Moffitt Medical Group
moffitt.org
HQ Phone
Get M.D. Eric's Phone Numberphone_androidMobile
Get M.D. Eric's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
FL State Medical License
2009 - 2027

American Board of Internal Medicine
Medical Oncology
University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General Hospital
Fellowship • Hematology and Medical Oncology
2009 - 2012
University of Florida
Residency • Internal Medicine
2006 - 2009
University Of Florida College Of Medicine
med.ufl.edu
Medical School
Until 2006
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 82 | 141 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 30 | 30 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 13 | 67 |
Authors: David Swoboda, Abhishek Mangaonkar, Rami Komrokji
Journal: Leuk Res
Publication Date: 2023-06-20
Authors: Andrew Kuykendall, Jeffrey Lancet, Kendra Sweet, Franco Castillo Tokumori, Seongseok Yun, Rami Komrokji, David Sallman, Chetasi Talati
Journal: Clin Lymphoma Myeloma Leuk
Publication Date: 2020-07-16
Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement.
Authors: Omar Abdel-Wahab, Ravindra Majeti, Stephen Nimer, Peter Greenberg, Rafael Bejar, Olatoyosi Odenike, Justin Taylor, Jan Philipp Bewersdorf, Gail Roboz, Hetty Carraway, Andrew Brunner, Mikkael Sekeres, Stephanie Halene, Amy Dezern, Amer Zeidan, Rami Komrokji, Zhuoer Xie, David Sallman, Sanam Loghavi, Peter Greenberg
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Darbepoetin Alfa, DRUG: Canakinumab Injection
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Intervention / Treatment: BIOLOGICAL: CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes, DRUG: Standard of Care Chemotherapy
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: National Institute of Nursing Research (NINR)
Journal: Blood